Shelley Amster

Co-Founder, Chief Strategy & Growth Officer at 3Daughters
  • Claim this Profile
Contact Information
Location
Concord, Massachusetts, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Steve Bannister

Shelley combines her technical training and experience with great communication and exceptional attention to detail to the advantage of the client. She is continuously expanding her network. Shelley is also continuously looking for connections and making introductions among her associates.

Balaji Bhyravbhatla

Shelley is a great person to work with, personable and trustworthy. She is using her network to bring in new business for Apelles and build the consortium in the Boston area. Balaji

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Co-Founder, Chief Strategy & Growth Officer
      • Oct 2021 - Present

      3Daughters is developing evolutionary healthcare products for women. Our lead product is an evolutionary designed intrauterine device (IUD), long-acting, reversible non-hormonal contraceptive. Our frameless, magnetic IUD is based on physics and geometry so it will conform naturally to a woman’s unique anatomy. 3Daughters addresses the pain ‘fear factor’ and other problems associated with all the current outdated T-shape IUDs, with no strings attached! 3Daughters is developing evolutionary healthcare products for women. Our lead product is an evolutionary designed intrauterine device (IUD), long-acting, reversible non-hormonal contraceptive. Our frameless, magnetic IUD is based on physics and geometry so it will conform naturally to a woman’s unique anatomy. 3Daughters addresses the pain ‘fear factor’ and other problems associated with all the current outdated T-shape IUDs, with no strings attached!

    • United States
    • Biotechnology
    • Founder & Principal
      • Jan 2008 - Present

      Shelley is the region's relationship bridge builder, change maker, and management integrator; a resource for busy entrepreneurs and executives needing to meet the right people for valuable business development alliances. You need to get something done, raise the bar, contact Shelley. Her friends consider her the number #1 resource, a great mentor and the most generous person in the community. Using a broad and deep (dependable) network comprising of virtual and early stage life science and healthcare companies, women’s health organizations, angel and venture capital investors, contract research organizations, non-profits, and government, ShelleyCO brings business leaders face to face with the resources and advisors to grow their business. Shelley opens doors and walks you down the red carpet to your next opportunity. Shelley was a pioneer in the infertility industry - developed one of the first sperm banks, male infertility assays, and was a member of the first IVF team at Yale, the second IVF Center in the US and has become the direct resource to KOLs and innovation in woman's health. Shelley continues to be a sought after resource for companies and organizations launching disruptive technologies to establish market acceptance, brand and build organizations to support these goals. Show less

    • United States
    • Biotechnology Research
    • Advisory Board
      • Jan 2016 - Present

      Mansfield Bio-Incubator is a non-profit organization whose mission is to facilitate and assist the creation, growth, and success of the next generation of biotech companies; train and educate future workers for these companies; and nurture entrepreneurial and economic development in the community, by maintaining affordable lab and office space, services, training, mentoring, and a network of professional advisors. We will provide entrepreneurs, innovative life-sciences start-ups, students and faculty of Massachusetts colleges and vocational schools with the space and resources they need to test out, challenge, and nurture early ideas and will teach students the skills for successful career in the biotech industry. Our goals are to: Support a collaborative atmosphere that allows thought-sharing and creative exchange Offer best-in-class infrastructure to enable the advanced practice and training of science, and technology Promote cost efficiency through sharing of many services Provide training and support in obtaining funding for future growth by facilitating the interaction with investors Teach and organize onsite and online seminars, courses and technical workshops to train interns and students new skills in fast growing areas of biotechnology Create an environment that stimulates creative interactions among industry, investors, government, and academia Show less

    • United States
    • Pharmaceutical Manufacturing
    • Co- Producer
      • Dec 2017 - Present

      The Annual Advancing Drug Development Forum - Making the Impossible Possible, Harnessing Small Molecules program builds on positive momentum and energy from our past meetings. Scheduled annually - next one December 2020 at The UMass Club Boston. Watch for details and registration go to www.advdrug.com The event is specifically designed to bring a focused group of KOLs, decision makers, senior scientists, c-suite executives, innovators and early adopters who are deeply involved in small molecule formulation development, CMC, drug product, drug substance and API manufacturing. Attendees with expertise and focus on implementation of (new) technologies that accelerate development and improve quality and the regulatory process are encouraged to attend in order to exchange ideas and experiences. These forums are designed to allow free-flowing dialogue and plenty of time has been woven throughout the day to assure quality interactive networking. Show less

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Advisory Board Member
      • Jun 2016 - Present

      Nephrogen is leading the fight against kidney disease in the 21st century. Nephrogen is a research-stage biotechnology company founded in August 2015 dedicated to developing novel therapeutics and medical devices for patients suffering from kidney disease and kidney failure. Our scientific founder has an extensive background in the fields of in vitro diagnostics, and CRISPR/Cas9 genome editing, and is personally motivated to apply these fields towards new treatments and cures in kidney medicine. Our broad patent portfolio and intellectual property protection will allow us to rapidly translate our technologies into viable therapeutic products. Show less

    • United States
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • MALSI Planning Committee
      • Jan 2009 - Present
    • Business & Scientific Affairs Consultant
      • Oct 2018 - Feb 2021

      ZyMōt Fertility is a business unit of DxNow, Inc. ZyMōt Sperm Separation Devices were designed and developed to aid reproductive medicine professionals in the separation of the healthiest and best-performing sperm for use in assisted reproductive technology (ART) procedures – without sperm-damaging centrifugation. Here’s how ZyMōt devices are optimizing lab procedures and redefining fertility results. DxNow, Inc. is a Maryland-based and globally recognized company pioneering ways to meet the needs of patients, clinics and labs around the world. Our dynamic management team combines 200+ years of biomedical industry experience and is backed by scientific and clinical advisors who have dedicated their lives to expanding possibilities in their fields of expertise. Every one of our ZyMōt Fertility advisors brings a great breadth of experience in transformative thinking and pioneering practices. DxNow's also is developing systems for animal breeding, forensics, renal dialysis, cancer, hematology, infectious disease, and life science research. Show less

    • United States
    • IT Services and IT Consulting
    • Board Of Directors
      • 2018 - Dec 2020

      Smart search database, relationship building, networking tool platform to help professionals identify untapped valuable contacts faster and easier! Smart search database, relationship building, networking tool platform to help professionals identify untapped valuable contacts faster and easier!

    • Business Development & Marketing Advisor
      • Jul 2017 - Jan 2020

      Responsible for developing high profile content forums led by and directed to key opinion leaders in small molecule drug development - formulation development through CMC. The forums focus on deep discussions around the challenges in developing complex compounds and learning how innovative technologies are breaking down the barriers. Shelley is also responsible for connecting her deep valued network aware of Juniper's strengths and capabilities, as well as showcasing Juniper at strategic conferences. Show less

    • Event Champion and Founder
      • 2011 - 2017

      Now in its 5th year, the MassBio CRO/CMO Symposium draws more than 300 attendees to discuss and evaluate the best practices that have evolved in shortening time to market. Through a series of panel discussions and breakout roundtables, we will evaluate the strategies that have evolved in outsourcing and strategic partnerships in discovery, pre-clinical, clinical and manufacturing. New this year, we have added 2 pre-conference workshops on 'Finding and Developing Strategic Partners' and "Selling to biotech and Pharma.' This year's program will also include opening and closing panel discussions, multiple breakout/roundtable discussions and a well-trafficked Exhibit Hall, and most valuable to everyone attending, significant networking time during breaks and the closing reception. This years event will take place at the Boston Marriott Cambridge, December 8th. Show less

    • Founder
      • Sep 2009 - 2016
    • United States
    • Research Services
    • Co-Founder, Vice President Operations & Business Development
      • Jan 2013 - Jul 2015

      The CreaGen Life Science Incubator (C2I) is the only chemistry-focused life science incubator in the Commonwealth providing a flexible, affordable facility for entrepreneurs to launch and build their companies, perform proof-of-concept studies and utilize their limited resources not on bricks and mortar and expensive equipment, but on their innovative research and their team. The mission is to create an environment that nurtures and supports promising entrepreneurs to have a better opportunity to accelerate. C2I welcomes and supports all entrepreneurs from a range of fields—including medical devices, diagnostics, biopharma and bioinformatics—who are passionate about creating products and services that advance the healthcare industry. These resources include shared office and laboratory resources, affordable rates, mentorship, access to experienced consultants, services and investment opportunities, and ample networking opportunities. C2I provides a real sense of community among members, our staff and the greater life science community network. Show less

    • VP of Business Development & Operations
      • Jan 2012 - Jul 2015

      CreaGen Biosciences is the resource for small molecule drug discovery chemistry. With a long history of providing quality organic/medicinal chemistry, CreaGen offers traditional, Structure-base Drug Design and High-Throughput Parallel Synthesis and Purification for lead generation and optimization, process research, and scale-up chemistry services for our academic, start-up biotechs and big pharma partners.. CreaGen Corporation Includes: - CreaGen Biosciences Integrated Project Group - CreaGen Chemistry Incubator - C2I - CreaGen Discovery Show less

    • Head of Business Development, US and Canada
      • Jan 2013 - Jan 2014

      TNC is the leading clinical research organization in Turkey committed to provide the highest quality clinical and regulatory services to local and international pharmaceutical and biotechnology companies. TNC offers the best Turkish clinics and patient populations to the sponsors’ specific needs, and carry out the planning, management, execution and reporting of bioavailability/bioequivalence and Phase I – IV clinical trials fulfilling the FDA and EMA standards. TNC is the leading clinical research organization in Turkey committed to provide the highest quality clinical and regulatory services to local and international pharmaceutical and biotechnology companies. TNC offers the best Turkish clinics and patient populations to the sponsors’ specific needs, and carry out the planning, management, execution and reporting of bioavailability/bioequivalence and Phase I – IV clinical trials fulfilling the FDA and EMA standards.

    • Business Development Consultant
      • 2011 - 2013
    • Vice President Business Development North America
      • Jun 2010 - Dec 2012
    • Director of Business Development
      • Jan 2008 - Jan 2010
    • Vice President, Biopharmaceutical & Life Sciences Conference Production
      • Jan 2007 - Nov 2007
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Conference Prod
      • 2005 - 2007
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Executive Director
      • 1997 - 2002

      Responsibilities included - fundraising, membership management and academic programming Responsibilities included - fundraising, membership management and academic programming

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Andrology Lab Supervisor
      • 1984 - 1992
    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • IVF & Andrology Lab Supervisor
      • 1982 - 1984

Education

  • University of New England
    BSMT, Medical Technology; Westbrook College
  • MRHS

Community

You need to have a working account to view this content. Click here to join now